Healthcare -
Biotechnology - NASDAQ - NL
$ 15.6
-1.89 %
$ 843 M
Market Cap
-5.71
P/E
PHVS - STOCK-BASED COMPENSATION
Stock-based Compensation PHVS - Pharvaris N.V.
10.7 M
LAST VALUE
14.06%
2 YEAR CAGR
154.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR